After-hours movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS

After-hours movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS

After-hours stock drives:

Spectrum Pharmaceuticals (NASDAQ:) 28% less; The U.S. Food and Drug Administration’s (FDA) Drug and Oncology Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations. The panel voted 9-4. However, the current benefits of poziotinib do not outweigh its risks.

Avenue Therapeutics, Inc. (NASDAQ 🙂 24% higher; It announced that it would affect a reverse split of 1 for 15 of its common stock.

Kano Health Inc (NYSE:) 5% higher; Adds to 32% of your daily winnings on reports for sale with multiple bidders.

CalAmp . Company (NASDAQ:) 4% higher; Earnings per share for the second quarter were reported ($0.02), $0.01 better than analysts’ estimates of ($0.03). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $69.27 million.

Costco (NASDAQ:) 3% less; Q4 EPS reported $4.20, $0.05 better than analyst estimates of $4.15. Revenue for the quarter came in at $72.09 billion versus the consensus estimate of $71.64 billion.

Goodwire (NYSE:) 3% higher; announced that its Board of Directors has approved a share buyback program with authorization to purchase up to $400.0 million of its outstanding shares in common stock, effective immediately.

Trevi Therapeutics, Inc. (NASDAQ 🙂 2% less; It started a guaranteed public offering of its common stock shares.

READ ALSO :   Pfizer/BioNTech seeks FDA approval for new pediatric COVID boosters

Newsletter Updates

Enter your email address below to subscribe to our newsletter